Cerenome, Inc. (CNSY)
NASDAQ: CNSY · Real-Time Price · USD
1.650
-0.050 (-2.94%)
Oct 19, 2026, 10:45 AM EDT - Market open
Cerenome Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4.2 | 5.21 | 5.82 | 4.91 | 0.22 | - | |
Revenue Growth | -20.95% | -10.49% | 18.54% | 2093.30% | -26.07% | - |
Cost of Revenue | 12.51 | 8.38 | 10.58 | 9.69 | 9.7 | 5.32 |
Gross Profit | -8.3 | -3.17 | -4.76 | -4.78 | -9.47 | -5.32 |
Selling, General & Admin | 18.1 | 12.13 | 9.94 | 8.54 | 10.24 | 6.85 |
Operating Expenses | 18.1 | 12.13 | 9.94 | 8.54 | 10.24 | 6.85 |
Operating Income | -26.4 | -15.3 | -14.7 | -13.32 | -19.71 | -12.18 |
Interest Expense | -0.02 | -0.55 | -0.18 | -0.4 | -0.71 | -0.93 |
Interest & Investment Income | 0.33 | 0.12 | 0.27 | 0.4 | 0.15 | 0.02 |
Other Non Operating Income (Expenses) | - | -6.66 | 1.62 | - | 0 | 0.01 |
EBT Excluding Unusual Items | -26.09 | -22.39 | -12.98 | -13.32 | -20.28 | -13.08 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | -0.07 |
Pretax Income | -26.09 | -22.39 | -12.98 | -13.32 | -20.28 | -13.4 |
Earnings From Continuing Operations | -26.09 | -22.39 | -12.98 | -13.32 | -20.28 | -13.4 |
Net Income | -26.09 | -22.39 | -12.98 | -13.32 | -20.28 | -13.4 |
Net Income to Common | -26.09 | -22.39 | -12.98 | -13.32 | -20.28 | -13.4 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 6 | 3 | 0 | 0 | 0 | 0 |
Shares Outstanding (Diluted) | 6 | 3 | 0 | 0 | 0 | 0 |
Shares Change | 830.64% | 910.35% | 145.18% | 79.45% | 117.18% | 173.02% |
EPS (Basic) | -4.34 | -7.19 | -48.86 | -105.99 | -289.58 | -415.63 |
EPS (Diluted) | -4.37 | -7.25 | -58.52 | -106.00 | -289.58 | -416.25 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -23.55 | -20.84 | -10.7 | -13.01 | -13.48 | -10.42 |
Free Cash Flow Per Share | -3.92 | -6.70 | -34.74 | -103.56 | -192.55 | -323.35 |
Gross Margin | -197.57% | -60.73% | -81.66% | -97.23% | - | - |
Operating Margin | -628.12% | -293.46% | -252.32% | -271.14% | -8800.00% | - |
Profit Margin | -620.70% | -429.43% | -222.84% | -271.04% | -9051.34% | - |
Free Cash Flow Margin | -560.29% | -399.81% | -183.72% | -264.83% | -6018.30% | - |
EBITDA | -25.95 | -14.85 | -13.82 | -12.69 | -19.09 | -11.78 |
EBITDA Margin | - | -284.92% | -237.34% | -258.35% | - | - |
D&A For EBITDA | 0.46 | 0.45 | 0.87 | 0.63 | 0.62 | 0.4 |
EBIT | -26.4 | -15.3 | -14.7 | -13.32 | -19.71 | -12.18 |
EBIT Margin | - | -293.46% | -252.32% | -271.14% | - | - |